Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

Clinical trial NCT07473167 · RECRUITING

Trial details

NCT number: NCT07473167
Sponsor: TICAROS Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Large B-cell Lymphoma Refractory Large B-cell Lymphoma Diffuse Large B-cell Lymphoma (DLBCL)High-grade B-cell Lymphoma (HGBL)Transformed Follicular Lymphoma (TFL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Start date: 2023-08-03
Primary completion: 2028-02-11
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.